Close
  Indian J Med Microbiol
 

Figure 2: Proportions of different comorbidities and CHA2DS2-VASc scores in AF patients. (a) Proportions of comorbidities in AF patients compared in Group 1 and Group 2, showing a downward trend in various comorbidities. (b) Mean annual follow-up visits per person with different CHA2DS2-VASc scores (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) in two groups, indicating that the visit frequency has distinctly increased. AF=Atrial fibrillation, HTN=Hypertension, DM=Diabetes mellitus, CAD=Coronary hear t disease, TIA=Transient ischemic attack, HF=Hear t failure, CKD=Chronic kidney disease. Groups 1 and 2: Before or after the establishment of comprehensive AF management platform

Figure 2: Proportions of different comorbidities and CHA<sub>2</sub>DS<sub>2</sub>-VASc scores in AF patients. (a) Proportions of comorbidities in AF patients compared in Group 1 and Group 2, showing a downward trend in various comorbidities. (b) Mean annual follow-up visits per person with different CHA<sub>2</sub>DS<sub>2</sub>-VASc scores (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) in two groups, indicating that the visit frequency has distinctly increased. AF=Atrial fibrillation, HTN=Hypertension, DM=Diabetes mellitus, CAD=Coronary hear t disease, TIA=Transient ischemic attack, HF=Hear t failure, CKD=Chronic kidney disease. Groups 1 and 2: Before or after the establishment of comprehensive AF management platform